SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sai Life Sciences informs about press release

08 Oct 2025 Evaluate
Sai Life Sciences has informed that Sai Life Sciences along with Agility Life Sciences and Centrix Pharma Solutions, has announced the launch of an Integrated CMC Partnership aimed at accelerating drug development for innovator biopharma companies. This strategic collaboration brings together the complementary strengths of the three organizations in Chemistry, Manufacturing and Controls (CMC), offering end-to-end services from API development to clinical manufacturing. Through this partnership, customers will have access to integrated drug substance and drug product development, helping them move efficiently from preclinical studies to first-in-human (FIH) clinical trials and beyond.

The above information is a part of company’s filings submitted to BSE.

Sai Life Sciences Share Price

970.50 -1.35 (-0.14%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×